Real-world evidence of survival outcomes in breast cancer subtypes after neoadjuvant chemotherapy in a Brazilian reference center
These updated real-world data (RWD) from BC patients who underwent NAC in Brazil revealed a pCR rate of 22.7% in all cancer subtypes and stages. pCR was not associated with better outcomes in patients with luminal A, contrasting with other subtypes.
Authors
- Luíz Henrique Gebrim (ORCID: https://orcid.org/0000-0001-9941-9191)
- Felipe Zerwes (ORCID: https://orcid.org/0000-0002-1643-727X)
- Marina Diogenes Teixeira
- Marcelo Antonini (ORCID: https://orcid.org/0000-0002-1996-7428)
- Francisco Pimentel Cavalcante (ORCID: https://orcid.org/0000-0002-7156-2890)
- Marcellus do Nascimento Moreira Ramos (ORCID: https://orcid.org/0009-0007-5486-118X)
- Fernanda Grace Bauk Richter (ORCID: https://orcid.org/0000-0003-3304-1231)
- Reginaldo Guedes Coelho Lopes (ORCID: https://orcid.org/0000-0002-7735-8698)
- Marcelo Madeira (ORCID: https://orcid.org/0000-0001-9429-3067)
- Gabriel Duque Pannain (ORCID: https://orcid.org/0000-0002-5164-3554)
- Odair Ferraro
- André Mattar (ORCID: https://orcid.org/0009-0003-2057-2188)
- Denise Joffily Pereira da Costa Pinheiro (ORCID: https://orcid.org/0000-0001-9812-9029)
- Leonardo Ribeiro Soares (ORCID: https://orcid.org/0000-0002-9448-6114)
- Andressa Gonçalves Amorim (ORCID: https://orcid.org/0000-0002-3077-5873)
Institutions
- Beneficência Portuguesa de São Paulo (BR)
Publication Details
- Journal
- Chinese Clinical Oncology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/cco-24-54
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.29